The Discounted Cash Flow (DCF) valuation of Neogenomics Inc (NEO) is (16.69) USD. With the latest stock price at 18.17 USD, the upside of Neogenomics Inc based on DCF is -191.9%.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| WACC / Discount Rate | 6.0% - 9.2% | 7.6% |
| Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
| Fair Price | (51.89) - (10.72) | (16.69) |
| Upside | -385.6% - -159.0% | -191.9% |